Lipopolysaccharide inhibits ghrelin-excited neurons of the arcuate nucleus and reduces food intake via central nitric oxide signaling

Brain, Behavior, and Immunity

Volumn 26, Issue 6, 2012, Pages 867-879

  Borner, Tito ^a   Pinkernell, Sarah ^a   Lutz, Thomas A ^a   Riediger, Thomas ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Anorexia; Arcuate nucleus; Electrophysiology; Ghrelin; Hypothalamus; Inflammation; Lipopolysaccharide; Nitric oxide

Indexed keywords

CYCLIC GMP; GHRELIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; STAT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARCUATE NUCLEUS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; ENERGY EXPENDITURE; ENZYME INHIBITION; FOOD INTAKE; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; NERVE CELL; NERVE CELL EXCITABILITY; NERVE CELL STIMULATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RESPIRATORY QUOTIENT; SIGNAL TRANSDUCTION;

AMIDINES; ANIMALS; ANOREXIA; ARCUATE NUCLEUS; BENZYLAMINES; CYCLIC GMP; EATING; ELECTROPHYSIOLOGICAL PHENOMENA; ENZYME INHIBITORS; GHRELIN; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; LIPOPOLYSACCHARIDES; MALE; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR;

EID: 84863860028     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.03.005     Document Type: Article

References (63)

1. Abram M., Vu kovic D., Wraber B., Doric M. Plasma cytokine response in mice with bacterial infection. Mediators Inflamm. 2000, 9:229-234.
2. Becskei C., Riediger T., Hernadfalvy N., Arsenijevic D., Lutz T.A., Langhans W. Inhibitory effects of lipopolysaccharide on hypothalamic nuclei implicated in the control of food intake. Brain Behav. Immun. 2008, 22:56-64.
3. Becskei C., Lutz T.A., Riediger T. Reduced fasting-induced activation of hypothalamic arcuate neurons is associated with hyperleptinemia and increased leptin sensitivity in obese mice. Am. J. Physiol. 2010, 299:R632-641.
4. Chen C.C., Chiu K.T., Sun Y.T., Chen W.C. Role of the cyclic AMP-protein kinase a pathway in lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages. Involvement of cyclooxygenase-2. J. Biol. Chem. 1999, 274:31559-31564.
5. Cowley M.A., Smith R.G., Diano S., Tschop M., Pronchuk N., Grove K.L., Strasburger C.J., Bidlingmaier M., Esterman M., Heiman M.L., Garcia-Segura L.M., Nillni E.A., Mendez P., Low M.J., Sotonyi P., Friedman J.M., Liu H., Pinto S., Colmers W.F., Cone R.D., Horvath T.L. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 2003, 37:649-661.
6. De Luca B., Monda M., Sullo A. Changes in eating behavior and thermogenic activity following inhibition of nitric oxide formation. Am. J. Physiol. 1995, 268:R1533-1538.
7. DeBoer M.D., Zhu X.X., Levasseur P., Meguid M.M., Suzuki S., Inui A., Taylor J.E., Halem H.A., Dong J.Z., Datta R., Culler M.D., Marks D.L. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 2007, 148:3004-3012.
8. Deboer M.D., Zhu X., Levasseur P.R., Inui A., Hu Z., Han G., Mitch W.E., Taylor J.E., Halem H.A., Dong J.Z., Datta R., Culler M.D., Marks D.L. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology 2008, 149:827-835.
9. Dell'Albani P., Santangelo R., Torrisi L., Nicoletti V.G., de Vellis J., Giuffrida Stella A.M. JAK/STAT signaling pathway mediates cytokine-induced iNOS expression in primary astroglial cell cultures. J. Neurosci. Res. 2001, 65:417-424.
10. Dickson S.L., Luckman S.M. Induction of c-fos messenger ribonucleic acid in neuropeptide Y and growth hormone (GH)-releasing factor neurons in the rat arcuate nucleus following systemic injection of the GH secretagogue, GH-releasing peptide-6. Endocrinology 1997, 138:771-777.
11. Edwards C.M., Abusnana S., Sunter D., Murphy K.G., Ghatei M.A., Bloom S.R. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J. Endocrinol. 1999, 160:R7-12.
12. Farr S.A., Banks W.A., Kumar V.B., Morley J.E. Orexin-a-induced feeding is dependent on nitric oxide. Peptides 2005, 26:759-765.
13. Feil R., Kleppisch T. NO/cGMP-dependent modulation of synaptic transmission. Handb. Exp. Pharmacol. 2008, 529-560.
14. Garcia J.M., Polvino W.J. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers. Oncologist 2007, 12:594-600.
15. Garcia J.M., Garcia-Touza M., Hijazi R.A., Taffet G., Epner D., Mann D., Smith R.G., Cunningham G.R., Marcelli M. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J. Clin. Endocrinol. Metab. 2005, 90:2920-2926.
16. Garcia J.M., Boccia R.V., Graham C., Kumor K., Polvino W.J. A phase II randomized, placebo-controlled, double-blind study of the efficacy abd safety of RC-1291 (RC) for the treatment of cancer cachexia. J. Clin. Oncol. 2007, 25:9133.
17. Garvey E.P., Oplinger J.A., Furfine E.S., Kiff R.J., Laszlo F., Whittle B.J., Knowles R.G. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 1997, 272:4959-4963.
18. Gaskin F.S., Farr S.A., Banks W.A., Kumar V.B., Morley J.E. Ghrelin-induced feeding is dependent on nitric oxide. Peptides 2003, 24:913-918.
19. Gautron L., Lafon P., Chaigniau M., Tramu G., Laye S. Spatiotemporal analysis of signal transducer and activator of transcription 3 activation in rat brain astrocytes and pituitary following peripheral immune challenge. Neuroscience 2002, 112:717-729.
20. Guo Z., Shao L., Du Q., Park K.S., Geller D.A. Identification of a classic cytokine-induced enhancer upstream in the human iNOS promoter. Faseb J. 2007, 21:535-542.
21. Hanada T., Toshinai K., Kajimura N., Nara-Ashizawa N., Tsukada T., Hayashi Y., Osuye K., Kangawa K., Matsukura S., Nakazato M. Anti-cachectic effect of ghrelin in nude mice bearing human melanoma cells. Biochem. Biophys. Res. Commun. 2003, 301:275-279.
22. Hart B.L. Biological basis of the behavior of sick animals. Neurosci. Biobehav. Rev. 1988, 12:123-137.
23. Hataya Y., Akamizu T., Hosoda H., Kanamoto N., Moriyama K., Kangawa K., Takaya K., Nakao K. Alterations of plasma ghrelin levels in rats with lipopolysaccharide-induced wasting syndrome and effects of ghrelin treatment on the syndrome. Endocrinology 2003, 144:5365-5371.
24. Hollis J.H., Lemus M., Evetts M.J., Oldfield B.J. Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression. Neuropharmacology 2010, 58:730-738.
25. Hollis J.H., Jonaidi H., Lemus M., Oldfield B.J. The endocannabinoid arachidonylethanolamide attenuates aspects of lipopolysaccharide-induced changes in energy intake, energy expenditure and hypothalamic Fos expression. J. Neuroimmunol. 2011, 233:127-134.
26. Jansky L., Vybiral S., Pospisilova D., Roth J., Dornand J., Zeisberger E., Kaminkova J. Production of systemic and hypothalamic cytokines during the early phase of endotoxin fever. Neuroendocrinology 1995, 62:55-61.
27. Kim O.S., Park E.J., Joe E.H., Jou I. JAK-STAT signaling mediates gangliosides-induced inflammatory responses in brain microglial cells. J. Biol. Chem. 2002, 277:40594-40601.
28. Kleinert H., Wallerath T., Fritz G., Ihrig-Biedert I., Rodriguez-Pascual F., Geller D.A., Forstermann U. Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br. J. Pharmacol. 1998, 125:193-201.
29. Kobayashi Y. The regulatory role of nitric oxide in proinflammatory cytokine expression during the induction and resolution of inflammation. J. Leukocyte Biol. 2010, 88:1157-1162.
30. 2+ signaling via protein kinase A and N-type channel-dependent mechanisms and cross-talk with leptin and orexin. Diabetes 2003, 52:948-956.
31. Konsman J.P., Vigues S., Mackerlova L., Bristow A., Blomqvist A. Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli. J. Comp. Neurol. 2004, 472:113-129.
32. Langhans W. Anorexia of infection: current prospects. Nutrition 2000, 16:996-1005.
33. Langhans W. Signals generating anorexia during acute illness. Proc. Nutr. Soc. 2007, 66:321-330.
34. Langhans W., Harlacher R., Scharrer E. Verapamil and indomethacin attenuate endotoxin-induced anorexia. Physiol. Behav. 1989, 46:535-539.
35. Langhans W., Savoldelli D., Weingarten S. Comparison of the feeding responses to bacterial lipopolysaccharide and interleukin-1 beta. Physiol. Behav. 1993, 53:643-649.
36. Lim C.P., Cao X. Structure, function, and regulation of STAT proteins. Mol. Biosyst. 2006, 2:536-550.
37. Lugarini F., Hrupka B.J., Schwartz G.J., Plata-Salaman C.R., Langhans W. A role for cyclooxygenase-2 in lipopolysaccharide-induced anorexia in rats. Am. J. Physiol. 2002, 283:R862-868.
38. Morley J.E., Alshaher M.M., Farr S.A., Flood J.F., Kumar V.B. Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: further evidence for a role of nitric oxide in feeding. Peptides 1999, 20:595-600.
39. Morley J.E., Farr S.A., Sell R.L., Hileman S.M., Banks W.A. Nitric oxide is a central component in neuropeptide regulation of appetite. Peptides 2011, 32:776-780.
40. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., Kangawa K. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005, 128:1187-1193.
41. Neary N.M., Small C.J., Wren A.M., Lee J.L., Druce M.R., Palmieri C., Frost G.S., Ghatei M.A., Coombes R.C., Bloom S.R. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J. Clin. Endocrinol. Metab. 2004, 89:2832-2836.
42. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Academic Press/Elsevier, Amsterdam, Boston.
43. Pecchi E., Dallaporta M., Jean A., Thirion S., Troadec J.D. Prostaglandins and sickness behavior: old story, new insights. Physiol. Behav. 2009, 97:279-292.
44. Plata-Salaman C.R. Anorexia during acute and chronic disease. Nutrition 1996, 12:69-78.
45. Riediger T., Traebert M., Schmid H.A., Scheel C., Lutz T.A., Scharrer E. Site-specific effects of ghrelin on the neuronal activity in the hypothalamic arcuate nucleus. Neurosci. Lett. 2003, 341:151-155.
46. Riediger T., Bothe C., Becskei C., Lutz T.A. Peptide YY directly inhibits ghrelin-activated neurons of the arcuate nucleus and reverses fasting-induced c-Fos expression. Neuroendocrinology 2004, 79:317-326.
47. Riediger T., Giannini P., Erguven E., Lutz T. Nitric oxide directly inhibits ghrelin-activated neurons of the arcuate nucleus. Brain. Res. 2006, 1125:37-45.
48. Riediger T., Cordani C., Potes C.S., Lutz T.A. Involvement of nitric oxide in lipopolysaccharide induced anorexia. Pharmacol. Biochem. Behav. 2010, 97:112-120.
49. Rummel C., Voss T., Matsumura K., Korte S., Gerstberger R., Roth J., Hubschle T. Nuclear STAT3 translocation in guinea pig and rat brain endothelium during systemic challenge with lipopolysaccharide and interleukin-6. J. Comp. Neurol. 2005, 491:1-14.
50. Rummel C., Sachot C., Poole S., Luheshi G.N. Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain. Am. J. Physiol. 2006, 291:R1316-1326.
51. Schmidt H.H., Lohmann S.M., Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta 1993, 1178:153-175.
52. Sergeyev V., Broberger C., Hokfelt T. Effect of LPS administration on the expression of POMC, NPY, galanin, CART and MCH mRNAs in the rat hypothalamus. Brain Res. Mol. Brain Res. 2001, 90:93-100.
53. Squadrito F., Calapai G., Cucinotta D., Altavilla D., Zingarelli B., Ioculano M., Urna G., Sardella A., Campo G.M., Caputi A.P. Anorectic activity of NG-nitro-l-arginine, an inhibitor of brain nitric oxide synthase, in obese Zucker rats. Eur. J. Pharmacol. 1993, 230:125-128.
54. Stempelj M., Kedinger M., Augenlicht L., Klampfer L. Essential role of the JAK/STAT1 signaling pathway in the expression of inducible nitric-oxide synthase in intestinal epithelial cells and its regulation by butyrate. J. Biol. Chem. 2007, 282:9797-9804.
55. Strassburg S., Anker S.D., Castaneda T.R., Burget L., Perez-Tilve D., Pfluger P.T., Nogueiras R., Halem H., Dong J.Z., Culler M.D., Datta R., Tschop M.H. Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats. Am. J. Physiol. 2008, 295:E78-84.
56. Strasser F., Lutz T.A., Maeder M.T., Thuerlimann B., Bueche D., Tschop M., Kaufmann K., Holst B., Brandle M., von Moos R., Demmer R., Cerny T. Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study. Br. J. Cancer 2008, 98:300-308.
57. Takeda K., Akira S. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 2000, 11:199-207.
58. Tedeschi E., Menegazzi M., Margotto D., Suzuki H., Forstermann U., Kleinert H. Anti-inflammatory actions of St. John's wort: inhibition of human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha (STAT-1alpha) activation. J. Pharmacol. Exp. Ther. 2003, 307:254-261.
59. Traebert M., Riediger T., Whitebread S., Scharrer E., Schmid H.A. Ghrelin acts on leptin-responsive neurones in the rat arcuate nucleus. J. Neuroendocrinol. 2002, 14:580-586.
60. Willesen M.G., Kristensen P., Romer J. Co-localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat. Neuroendocrinology 1999, 70:306-316.
61. Wisse B.E., Frayo R.S., Schwartz M.W., Cummings D.E. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 2001, 142:3292-3301.
62. Wong M.L., Rettori V., al-Shekhlee A., Bongiorno P.B., Canteros G., McCann S.M., Gold P.W., Licinio J. Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nat. Med. 1996, 2:581-584.
63. Woods S.C., Seeley R.J., Porte D., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science 1998, 280:1378-1383.